130 related articles for article (PubMed ID: 37188041)
1. Correlation Between Tumor-Associated Collagen Signature and Fibroblast Activation Protein Expression With Prognosis of Clear Cell Renal Cell Carcinoma Patient.
Warli SM; Putrantyo II; Laksmi LI
World J Oncol; 2023 Apr; 14(2):145-149. PubMed ID: 37188041
[TBL] [Abstract][Full Text] [Related]
2. The Expression of Fibroblast Activation Protein in Clear Cell Renal Cell Carcinomas Is Associated with Synchronous Lymph Node Metastases.
Errarte P; Guarch R; Pulido R; Blanco L; Nunes-Xavier CE; Beitia M; Gil J; Angulo JC; López JI; Larrinaga G
PLoS One; 2016; 11(12):e0169105. PubMed ID: 28033421
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
4. Altered Tissue and Plasma Levels of Fibroblast Activation Protein-α (FAP) in Renal Tumours.
Solano-Iturri JD; Errarte P; Etxezarraga MC; Echevarria E; Angulo J; López JI; Larrinaga G
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33207686
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of RASSF1A tumor suppressor gene is associated with worse prognosis in clear cell renal cell carcinoma.
Klacz J; Wierzbicki PM; Wronska A; Rybarczyk A; Stanislawowski M; Slebioda T; Olejniczak A; Matuszewski M; Kmiec Z
Int J Oncol; 2016 Jan; 48(1):55-66. PubMed ID: 26648328
[TBL] [Abstract][Full Text] [Related]
6. The Association Between PD-L1 Expression and the Clinical Outcomes to Vascular Endothelial Growth Factor-Targeted Therapy in Patients With Metastatic Clear Cell Renal Cell Carcinoma.
Shin SJ; Jeon YK; Cho YM; Lee JL; Chung DH; Park JY; Go H
Oncologist; 2015 Nov; 20(11):1253-60. PubMed ID: 26424759
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of fibroblast activation protein-α (FAP) in colorectal adenoma-carcinoma sequence and in lymph node and liver metastases.
Solano-Iturri JD; Beitia M; Errarte P; Calvete-Candenas J; Etxezarraga MC; Loizate A; Echevarria E; Badiola I; Larrinaga G
Aging (Albany NY); 2020 May; 12(11):10337-10358. PubMed ID: 32428869
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast Activation Protein-α Expressing Fibroblasts Promote Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma.
Li F; Wu X; Sun Z; Cai P; Wu L; Li D
Onco Targets Ther; 2020; 13():8141-8148. PubMed ID: 32884296
[TBL] [Abstract][Full Text] [Related]
9. Aligned collagen is a prognostic signature for survival in human breast carcinoma.
Conklin MW; Eickhoff JC; Riching KM; Pehlke CA; Eliceiri KW; Provenzano PP; Friedl A; Keely PJ
Am J Pathol; 2011 Mar; 178(3):1221-32. PubMed ID: 21356373
[TBL] [Abstract][Full Text] [Related]
10. Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness.
Serie DJ; Joseph RW; Cheville JC; Ho TH; Parasramka M; Hilton T; Thompson RH; Leibovich BC; Parker AS; Eckel-Passow JE
Eur Urol; 2017 Jun; 71(6):979-985. PubMed ID: 27899233
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast activation protein predicts prognosis in clear cell renal cell carcinoma.
López JI; Errarte P; Erramuzpe A; Guarch R; Cortés JM; Angulo JC; Pulido R; Irazusta J; Llarena R; Larrinaga G
Hum Pathol; 2016 Aug; 54():100-5. PubMed ID: 27063470
[TBL] [Abstract][Full Text] [Related]
12. Effect of glandular metastases on overall survival of patients with metastatic clear cell renal cell carcinoma in the antiangiogenic therapy era.
Gravis G; Chanez B; Derosa L; Beuselinck B; Barthelemy P; Laguerre B; Brachet PE; Joly F; Escudier B; Harrison DJ; Laird A; Vasudev N; Ralph C; Larkin J; Lote H; Salem N; Walz J; Thomassin J; Sfumato P; Stewart GD; Boher JM;
Urol Oncol; 2016 Apr; 34(4):167.e17-23. PubMed ID: 26670200
[TBL] [Abstract][Full Text] [Related]
13. Effects of the fibroblast activation protein on the invasion and migration of gastric cancer.
Wang RF; Zhang LH; Shan LH; Sun WG; Chai CC; Wu HM; Ibla JC; Wang LF; Liu JR
Exp Mol Pathol; 2013 Dec; 95(3):350-56. PubMed ID: 24422232
[TBL] [Abstract][Full Text] [Related]
14. High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis.
Wikberg ML; Edin S; Lundberg IV; Van Guelpen B; Dahlin AM; Rutegård J; Stenling R; Oberg A; Palmqvist R
Tumour Biol; 2013 Apr; 34(2):1013-20. PubMed ID: 23328994
[TBL] [Abstract][Full Text] [Related]
15. The coexpression of fibroblast activation protein (FAP) and basal-type markers (CK 5/6 and CD44) predicts prognosis in high-grade invasive urothelial carcinoma of the bladder.
Calvete J; Larrinaga G; Errarte P; Martín AM; Dotor A; Esquinas C; Nunes-Xavier CE; Pulido R; López JI; Angulo JC
Hum Pathol; 2019 Sep; 91():61-68. PubMed ID: 31279874
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of fibroblast activation protein-α in non-small cell lung cancer after curative resection: a new predictor for prognosis.
Liao Y; Ni Y; He R; Liu W; Du J
J Cancer Res Clin Oncol; 2013 Sep; 139(9):1523-8. PubMed ID: 23835897
[TBL] [Abstract][Full Text] [Related]
18. Genetic profile and immunohistochemical study of clear cell renal carcinoma: Pathological-anatomical correlation and prognosis.
Diez-Calzadilla NA; Noguera Salvá R; Soriano Sarrió P; Martínez-Jabaloyas JM
Cancer Treat Res Commun; 2021; 27():100374. PubMed ID: 33932757
[TBL] [Abstract][Full Text] [Related]
19. [Expression and significance of fibroblast growth factor receptor 2 in clear cell renal cell carcinoma].
Cai TY; Zhu ZP; Xu CR; Ji X; Lv TD; Guo ZK; Lin J
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):628-635. PubMed ID: 35950384
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a prognostic nomogram for predicting cancer-specific survival in patients with metastatic clear cell renal carcinoma: A study based on SEER database.
Huang G; Liao J; Cai S; Chen Z; Qin X; Ba L; Rao J; Zhong W; Lin Y; Liang Y; Wei L; Li J; Deng K; Li X; Guo Z; Wang L; Zhuo Y
Front Oncol; 2022; 12():949058. PubMed ID: 36237316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]